This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX USA Congress

⏳ Launch offer ends in...

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Connecting Innovators with Strategic Knowledge & Capital
September 11th - 12th, 2024Hynes Convention Centre, Boston, MA, USA

Wyatt McDonnell
CEO at Infinimmune, Inc.
Speaker

Profile

Dr. Wyatt McDonnell is Co-Founder, CEO, and Chairman of the Board of Directors at Infinimmune, a biotechnology company utilizing natural immunity to transform natural antibodies into safer and more effective drugs for complex diseases. Previously, Wyatt worked on world-class single cell technologies at 10x Genomics where he was Technical Lead and Developer of Barcode-Enabled Antigen Mapping (BEAM). Wyatt also developed 10x Genomics’ first therapeutic antibodies and core immunology intellectual property behind three commercial products to interrogate the immune repertoire. He has co-authored 31 peer-reviewed papers in journals including Nature, Cell, and Nature Medicine, and 19 published patents in relation to immunobiology, genomics, and disease. He has been invited to speak at conferences including PEGS, the Keystone Symposia, the World Vaccine Congress, and PMWC.

Agenda Sessions

  • What is Required to Scale? Fast-Tracking Biotech Growth

    11:00am